Seres Therapeutics (NASDAQ:MCRB) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Seres Therapeutics missed estimated earnings by 25.0%, reporting an EPS of $-0.55 versus an estimate of $-0.44.
Revenue was up $10.34 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.18 which was followed by a 8.34% drop in the share price the next day.
Here's a look at Seres Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.46 | -0.37 | -0.31 | -0.28 |
| EPS Actual | 0.72 | -0.53 | -0.39 | -0.19 |
| Revenue Estimate | 7.32M | 5.34M | 6.45M | 6.93M |
| Revenue Actual | 126.72M | 5.26M | 5.72M | 17.56M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
